6 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... During Anticoagulation ... Hypercoagulability ot Ca ... #hematology #differential ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for appropriate dosing ... DVT = deep vein ... ; VTE = venous thromboembolism ... #Algorithm #Anticoagulation ... #Management #Hematology
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... catheter-directed thrombolysis ... CAT = cancer-associated ... inferior vena cava ... #dvt #vte #thromboembolism
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Therapy for Venous Thromboembolic ... Prevention of post-thrombotic ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... #hematology #length
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... without concomitant DVT ... bleeding risk during ... #Algorithm #Anticoagulation ... #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous Thromboembolism ... Treatment Algorithm ... Isolated distal DVT ... #management #hematology ... #anticoagulation